NCT07663617

Brief Summary

This study will be conducted to investigate the effect of mechanical traction on pain, disability, cervical range of motion, sleep quality and insomnia in patients with chronic neck pain. Forty four female patients with chronic neck pain will participate in this study. The patients will be diagnosed as having chronic neck pain based on careful clinical examination by neurologist. Patients in this study will be randomly divided into two equal groups: Group (A): Patients in this group will receive mechanical traction for 20 minutes in addition to conventional physical therapy. Group (B): Patients in this group will receive conventional physical therapy only. The treatment will be conducted over six weeks, three days per week.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 23, 2026

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2026

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Completed
Last Updated

June 23, 2026

Status Verified

June 1, 2026

Enrollment Period

2 months

First QC Date

June 17, 2026

Last Update Submit

June 17, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • pain intensity

    The visual analog scale (VAS) is frequently used to measure pain intensity in patients with cervical spine disorders. The minimum clinically important difference (MCID) is the smallest change in a score that has clinical importance to the patient. Although it has been established for other medical fields, knowledge of the VAS MCID for the cervical spine is sparse, and it has rarely been considered in relation to measurement noise. the score represented in numbers from 0 to 10.

    pre intervention and re assessed after 6 weeks of treatment

  • neck disability

    neck disability index questionnaire was used to assess the disability caused by neck pain. The Neck disability index is a commonly used method to determine functional disability level of subjects with neck pain. it is a 10-item questionnaire used to measure self-reported disability related to neck pain, with higher scores indicating greater functional limitation, Each section is scored from 0 to 5, where 0 indicates no disability and 5 indicates maximum disability. The total raw score ranges from 0 to 50, which can be converted to a percentage by doubling the score, giving a range from 0% (no disability) to 100% (complete disability),

    pre intervention and re assessed after 6 weeks of treatment

  • Cervical Range of Motion (CROM)

    Cervical Range of Motion (CROM) device. The CROM device is a type of goniometer designed specifically for the cervical spine and was used to measure cervical ROM. It consists of a plastic frame that is mounted over the subject's nose bridge and ears and secured to the head by a felcro strap. Three independent inclinometers attached to the frame and arranged orthogonally to one another indicate the subject's cervical ROM. Cervical Range of Motion (CROM) is measured in angles

    pre intervention and re assessed after 6 weeks of treatment

  • sleep quality

    Pittsburg Sleep Quality Index (PSQI) is used to assess sleep quality. The Pittsburg sleep quality index is a self administered questionnaire used to assess sleep quality. It is considered the gold standard for evaluating sleep quality over a period of 1 month. It consists of 19 items and were calculated as the following 7 components: sleep latency, sleep duration, sleep quality, sleep disturbances, sleep efficiency, sleep medication, and daytime dysfunction. Each component of them was weighted equally and scored on a scale from 0-3 for a total score from 0-21. Its validity is confirmed by various studies in different populations of patients

    pre intervention and re assessed after 6 weeks of treatment

  • Insomnia Severity

    The Insomnia Severity Index (ISI) is used to assess insomnia. Itis a seven-question questionnaire that is given to the respondent to assess recent problems with falling asleep, maintaining sleep, early awakening and the consequences of insomnia, using five-level points (from 0-none to 4-very, a lot). The ISI score is obtained by summing the points for each item, and it ranges from 0 to 28. Higher scores correspond to insomnia of greater intensity, and can be classified into four categories: no insomnia (0-7), borderline insomnia (8-14), clinically clear insomnia-moderately severe (15-21) and clinically clear insomnia-severe (22-28)

    pre intervention and re assessed after 6 weeks of treatment

Study Arms (2)

Group A (exprimental)

EXPERIMENTAL

Patients in this group will receive mechanical traction for 20 minutes in addition to conventional physical therapy. The treatment will be conducted over six weeks, three days per week.

Device: mechanical tractionDevice: conventional physical therapy

Group B(control)

ACTIVE COMPARATOR

Patients in this group will receive conventional physical therapy only. The treatment will be conducted over six weeks, three days per week.

Device: conventional physical therapy

Interventions

Participants will be positioned in supine on a flat bed. A manual traction test will be performed to ensure that traction did not provoke any pain or unwanted sensations.The mechanical traction will be applied at 45° from the horizontal plane formed by the bed Mechanical traction was set to 5% of the participant's body weight on day 1 (unless not tolerated) and increased to reach 10% on the 5th day, as pain allowed, and without exceeding 12kg. Within a session, the load will applied progressively over 5 minutes and pain will be monitored using a VAS. The target weight will be then maintained for 20 minutes and then reduced gradually over the last 5 minutes. The patient then will lie still for 10 minutes before getting up Patients recieved conventional physical therapy treatment in addition to mechanical traction conducted over six weeks, three days per week.

Group A (exprimental)

Patients recieved conventional physical therapy which will include: 1-10 minute hot packs on the cervical and upper back. 2- Ultrasound: It will be applied to paraspinal muscles with a frequency of 1 MHz with a continuous mode and 0.5 W/Cm2 for 5 minutes using moving sound head technique. 3- Transcutaneous electrical nerve stimulation: The electrodes will be placed at the level of cervical paraspinal muscles and at the course of affected nerve. The impulse duration will be adjusted to 1ms with an interval of 5 ms. and frequency of 166 Hz for 20 minutes The treatment will be conducted over six weeks, three days per week.

Group A (exprimental)Group B(control)

Eligibility Criteria

Age30 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female Patients with chronic neck pain.
  • The age of patients will be ranged from 30-45 years old.
  • Duration of pain will be more than six months.

You may not qualify if:

  • Other neurological disorders causing sleep disorders as stroke and multiple sclerosis.
  • Pregnancy.
  • History of cervical spine surgery.
  • Psychological disorders such as severe depression or anxiety.
  • Active infection or malignancy in the cervical spine.
  • Body mass index more than 30kg/m2.
  • Diabetic or peripheral neuropathy.
  • Severe myelopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
lecturer of physical therapy

Study Record Dates

First Submitted

June 17, 2026

First Posted

June 23, 2026

Study Start

April 20, 2026

Primary Completion

June 25, 2026

Study Completion

July 1, 2026

Last Updated

June 23, 2026

Record last verified: 2026-06

Locations